Diagnosis of Laryngeal Lesions Using the Probe-based Confocal Laser Endomicroscopy
The Diagnosis of Laryngeal Lesions Using the Probe-based Confocal Laser Endomicroscopy in Vivo
1 other identifier
observational
60
1 country
1
Brief Summary
To evaluate the diagnosis of laryngeal lesions using the Probe-based Confocal Laser Endomicroscopy in vivo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 22, 2019
CompletedFirst Posted
Study publicly available on registry
October 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2020
CompletedJanuary 7, 2020
January 1, 2020
2.5 years
October 22, 2019
January 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pCLE diagnostic classification
Evaluation of pCLE diagnostic performance for the diagnosis of Laryngeal Lesions when associated with other diagnostic information.
6 months
Secondary Outcomes (1)
the image analysis by machine learning
6 months
Study Arms (3)
normal mucosa
Flat and relatively uniform polygonal epithelial cells with alternating dark and light bands were noted in pCLE images of normal mucosa after intravenous injecting 10% fluorescein.
non-malignant lesions
An unorganized tissue architecture, irregular cells (difference of cell shape, color and size), slightly intensified fluorescein leakage, and vessels not assessable were found in the lymphoid hyperplasia of non-malignant lesions after intravenous injecting 10% fluorescein.
malignant lesions
pCLE images of malignant lesions were associated with crowded unorganized tissue architecture (a dark-gray background without identification of mucosal structures), irregular cells like cell clusters, amplified fluorescein leakage, and irregular vessels changes after intravenous injecting 10% fluorescein.
Interventions
Confocal laser microendoscopy (CLE) as a new non-invasive imaging technique can be used for "optical biopsy", which can perform real-time microscopic information of tissue in vivo at cellular level with resolutions up to 1μm and magnifications up to 1000 times. CLE is now being increasingly used with very promising results in gastroenterology, especially in the diagnostic investigation of Barret's esophagus, stomach cancer, colorectal cancer and various lesions of the biliary tract. With an intravenous injection of fluorescein, probe-based CLE (pCLE: GastroFlex probe with the Cellvizio laser system, Mauna Technologies, Paris, France) allows us to view the interstitial spaces, cells, and small capillaries in a window of 240 μm and to a depth of 60 μm.
Eligibility Criteria
All patients with suspicious unidentified lesions were collected in this study in Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, who need to be underwent microscopic laryngoscopy.
You may qualify if:
- ≤Male or female age ≤85 years old;
- patients with vocal cord lesions founded by white light laryngoscope and needed to perform laryngeal microsurgery;
- Willing and able to comply with study procedures and provide written informed consent to participate in the study.
You may not qualify if:
- Male or female \<18 years old, or Male or female \>85 years;
- The patient has abnormal blood or coagulation function, and there is a risk of bleeding during the examination;
- The patient has severe cardiopulmonary function or liver and kidney dysfunction and cannot tolerate surgery.
- The patient has a history of allergies to drugs or food.
- The patient has a positive serotonin sodium allergy test and is allergic to sodium fluorescein;
- Lactation or pregnant women.
- Refusal to sign the informed consent form.
- Others who do not take this test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University
Shanghai, Shanghai Municipality, 200031, China
Study Officials
- STUDY CHAIR
Huawei Li, PhD &MD
Otorhinolaryngology Department of Eye & ENT Hospital, Fudan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2019
First Posted
October 25, 2019
Study Start
June 1, 2017
Primary Completion
November 30, 2019
Study Completion
December 21, 2020
Last Updated
January 7, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share